Antibody-Drug Conjugates in Breast Cancer: What Is Beyond HER2? : The Cancer Journal

Secondary Logo

Journal Logo

Review Articles

Antibody-Drug Conjugates in Breast Cancer: What Is Beyond HER2?

Nicolò, Eleonora MD∗,†; Repetto, Matteo MD∗,†; Boscolo Bielo, Luca MD∗,†; Tarantino, Paolo MD∗,†,‡; Curigliano, Giuseppe MD, PhD∗,†

Author Information
The Cancer Journal 28(6):p 436-445, 11/12 2022. | DOI: 10.1097/PPO.0000000000000629

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid